DALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announceDALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce

New Outpatient Infusion Center Opening in Marietta, GA Expands the National Presence of Advanced Infusion Care

DALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country.

The opening of more and more AICC sites highlights AIC’s strategic dedication to addressing the rising demand for outpatient infusion therapy. Designed based on a modern, patient-focused approach, the Centers emphasize comfort, convenience, and clinical excellence. Now accepting referrals, the Marietta location is ready to deliver individualized infusion therapy to the patients who depend on these services in the greater Atlanta region.

“We are truly excited to open our new infusion Center in Marietta, GA as it represents another meaningful step in our mission to bring high-quality, personalized care closer to the patients who need it most,” said Simon Castellanos, CEO of AIS Healthcare. “This expansion allows us to better support the community while continuing to raise the standard for outpatient infusion services nationwide.”

Offering a wide range of therapies for both long-term and short-term conditions, AICC—including the Marietta location—ensure that patients have access to the newest FDA-approved treatments. The Centers are built to support diverse clinical needs, with specialties in neurology, gastroenterology, rheumatology, dermatology, immunology, pulmonology, ophthalmology, and endocrinology. In Marietta, patients will find private treatment rooms for added comfort, flexible scheduling options, and highly skilled clinical staff.

“At AIC, we understand that infusion therapy is more than a procedure—it’s an essential part of a patient’s overall health and quality of life,” said Jud Hall, President of AIC. “Our approach is centered on reducing wait times and increasing meaningful care. With private rooms, adaptable appointment options, and highly trained medical professionals, we ensure that every patient receives care designed around their needs.”

As a full-service partner to clinicians, AIC works collaboratively with provider offices, insurance companies, and patients to secure all required authorizations and approvals. Dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC) further sets AIC apart as a trusted leader in infusion care.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

Contacts

Jud Hall

877.443.4006

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week

Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week

TLDR Bitcoin ETFs recorded their strongest weekly inflows since July, reaching 20,685 BTC. U.S. Bitcoin ETFs contributed nearly 97% of the total inflows last week. The surge in Bitcoin ETF inflows pushed holdings to a new high of 1.32 million BTC. Fidelity’s FBTC product accounted for 36% of the total inflows, marking an 18-month high. [...] The post Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week appeared first on CoinCentral.
Share
Coincentral2025/09/18 02:30
XAG/USD retreats toward $113.00 on profit-taking pressure

XAG/USD retreats toward $113.00 on profit-taking pressure

The post XAG/USD retreats toward $113.00 on profit-taking pressure appeared on BitcoinEthereumNews.com. Silver price (XAG/USD) halts its seven-day winning streak
Share
BitcoinEthereumNews2026/01/30 10:21
BTC Leverage Builds Near $120K, Big Test Ahead

BTC Leverage Builds Near $120K, Big Test Ahead

The post BTC Leverage Builds Near $120K, Big Test Ahead appeared on BitcoinEthereumNews.com. Key Insights: Heavy leverage builds at $118K–$120K, turning the zone into Bitcoin’s next critical resistance test. Rejection from point of interest with delta divergences suggests cooling momentum after the recent FOMC-driven spike. Support levels at $114K–$115K may attract buyers if BTC fails to break above $120K. BTC Leverage Builds Near $120K, Big Test Ahead Bitcoin was trading around $117,099, with daily volume close to $59.1 billion. The price has seen a marginal 0.01% gain over the past 24 hours and a 2% rise in the past week. Data shared by Killa points to heavy leverage building between $118,000 and $120,000. Heatmap charts back this up, showing dense liquidity bands in that zone. Such clusters of orders often act as magnets for price action, as markets tend to move where liquidity is stacked. Price Action Around the POI Analysis from JoelXBT highlights how Bitcoin tapped into a key point of interest (POI) during the recent FOMC-driven spike. This move coincided with what was called the “zone of max delta pain”, a level where aggressive volume left imbalances in order flow. Source: JoelXBT /X Following the test of this area, BTC faced rejection and began to pull back. Delta indicators revealed extended divergences, with price rising while buyer strength weakened. That mismatch suggests demand failed to keep up with the pace of the rally, leaving room for short-term cooling. Resistance and Support Levels The $118K–$120K range now stands as a major resistance band. A clean move through $120K could force leveraged shorts to cover, potentially driving further upside. On the downside, smaller liquidity clusters are visible near $114K–$115K. If rejection holds at the top, these levels are likely to act as the first supports where buyers may attempt to step in. Market Outlook Bitcoin’s next decisive move will likely form around the…
Share
BitcoinEthereumNews2025/09/18 16:40